The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...
Norcros plc announced an Investor Presentation Webinar to discuss its Interim Results for the 27 weeks ending 5th October 2025. The event, led by CEO Thomas Willcocks and CFO James Eyre, is open to ...